Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: a randomized controlled trial - Wikidata - awgldk - TriplyDB

Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: a randomized controlled trial

Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: a randomized controlled trial

http://www.wikidata.org/entity/Q36868568

about

HIV infection and cardiovascular disease The Role of the Growth Hormone/Insulin-Like Growth Factor System in Visceral Adiposity.Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: A randomized, placebo-controlled trial.Effects of switching from lopinavir/ritonavir to atazanavir/ritonavir on muscle glucose uptake and visceral fat in HIV-infected patients.Relationship of peak growth hormone to cardiovascular parameters, waist circumference, lipids and glucose in HIV-infected patients and healthy adults.HIV-associated lipodystrophy: a review from a Brazilian perspective Update on human health concerns of recombinant bovine somatotropin use in dairy cows.Effects of a growth hormone-releasing hormone analog on endogenous GH pulsatility and insulin sensitivity in healthy men.Reduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin.Pathogenesis and treatment of HIV infection: the cellular, the immune system and the neuroendocrine systems perspective.Effects of growth hormone-releasing hormone on visceral fat, metabolic, and cardiovascular indices in human studies.Lipodystrophy: pathophysiology and advances in treatment Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial Effects of low-dose growth hormone withdrawal in patients with HIV.Insulin-like growth factors and related proteins in plasma and cerebrospinal fluids of HIV-positive individuals.Growth hormone and tesamorelin in the management of HIV-associated lipodystrophy Management of the metabolic effects of HIV and HIV drugs.Leptin in relation to the lipodystrophy-associated metabolic syndrome Effects of growth hormone withdrawal in obese premenopausal women Fat Matters: Understanding the Role of Adipose Tissue in Health in HIV Infection A pilot study of telmisartan for visceral adiposity in HIV infection: the metabolic abnormalities, telmisartan, and HIV infection (MATH) trial.Benefits of leptin therapy in HIV patients.Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial.Low and Normal IGF-1 Levels in Patients with Chronic Medical Disorders (CMD) is Independent of Anterior Pituitary Hormone Deficiencies: Implications for Treating IGF-1 Abnormal Deficiencies with CMD Pathogenesis and treatment of HIV lipohypertrophy Effect of Recombinant Human Growth Hormone and Rosiglitazone for HIV-Associated Abdominal Fat Accumulation on Adiponectin and other Markers of Inflammation Tesamorelin: a review of its use in the management of HIV-associated lipodystrophy.Management of fat accumulation in patients with HIV infection.The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations.An update on the pharmacological strategies in the treatment of HIV-1-associated adipose redistribution syndromes.Recombinant Human Growth Hormone: HIV-Related Lipodystrophy.Adult growth hormone deficiency treatment with a combination of growth hormone and insulin-like growth factor-1 resulting in elevated sustainable insulin-like growth factor-1 and insulin-like growth factor binding protein 3 plasma levels: a case rep Whither recombinant human leptin treatment for HIV-associated lipoatrophy and the metabolic syndrome?Low-dose growth hormone for 40 weeks induces HIV-1-specific T cell responses in patients on effective combination anti-retroviral therapy.Effects of recombinant human growth hormone administration on cardiovascular risk factors in obese children with relative growth hormone deficiency.

P2860

Q27008915-9FB0688E-F30A-418F-A9E4-4A070694C849 Q33602919-35A285F0-D004-4A8F-A451-6B9E7B1D9D37 Q33803331-1E83C917-8144-4589-974D-545A4222E636 Q33918414-FF1E5C99-4E75-4BAC-9A12-E7937BAD05DF Q33926905-B2454B2E-59EA-4A5D-9C28-21494B5A782D Q33939681-E205224B-105F-4BD2-8A1F-8C2F35A8C177 Q34411789-082833E1-A4E3-430A-96CD-CB9B395E47AB Q34571826-1BF635FB-5EAD-4A04-915E-DFD8AE7CC798 Q34637395-070D444F-AC8B-46EA-B28B-96037A5F9A03 Q34650866-4065FB7A-A065-4C72-9504-343F56D96452 Q35072510-61B5E3AD-248C-4508-9455-7F0197718C62 Q35148915-DA1ECC68-9569-476D-916A-337F514A916F Q35186541-214BCF3D-0FF6-4989-8C0B-696525ED761E Q35482271-C2355A81-5231-432D-A2D2-5B7ABF13B98B Q35530481-49275082-9DBE-4DBA-AA32-42197EC0E80F Q35557342-10E3176F-54DD-4AC5-8C37-E85EED00779B Q36021411-74DE297A-FF39-457E-AAD4-65765F9A5150 Q36049195-F23BC287-5054-4A2A-A165-2C60A75824DD Q36652243-D18D105F-3310-490F-BFD4-2E711A656CAD Q36654972-FA9A2B3B-03DB-4294-9DC6-E457C76EB978 Q36684708-837509E5-0AA4-4C39-B1A4-91800BD97017 Q36700922-2CB4A0BF-8216-4414-AAC4-0B6661C1D43F Q36765204-85FD04BA-AFB3-4E9B-8794-8A10CA0E05C3 Q36784361-CB589799-62D4-4318-9414-68419C2A56C3 Q36900984-19C76861-B5FF-4AFE-BC81-9137F55939CA Q37085712-C8D6ED50-0603-4CDB-A98C-396D9D60D9C8 Q37888672-FC45D132-9092-45C5-8EBE-B84EF028E3AB Q37899071-EC8E83AE-AB9C-4444-9529-BE34EAA1F952 Q38097351-795C351D-2FF9-48EA-9ADB-A372E3DE9669 Q38220651-85608F6B-936E-465C-AE70-4CCD01E41CE7 Q40864476-F5A60FA6-6B0D-4136-8114-67FD9F972AA4 Q42409944-F4989B90-7BC2-40FE-A9A6-0E3FAEEBA271 Q43066028-DCA2D199-D0F0-4CBC-96B6-CEEB281A179C Q50899394-ED275056-0E37-4841-A23A-C33E1AEB2362 Q53698784-47F5037A-350D-41E1-BBEC-20D3A6973D24

P2860

Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: a randomized controlled trial

http://www.wikidata.org/entity/Q36868568

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Low-dose physiological growth ...... a randomized controlled trial

@en

type

label

Low-dose physiological growth ...... a randomized controlled trial

@en

prefLabel

Low-dose physiological growth ...... a randomized controlled trial

@en

P1433

Q36868568-4C9CB5D3-C6DF-4468-A1CB-3CDC613BE122

P1476

Q36868568-411181E8-DDDF-4A40-AFDF-ECC17F229BBF

P2093

Q36868568-3E53BCCD-0A32-4E96-870D-319CA0B43312

Q36868568-48807BBC-11EB-45CF-80F6-598F1CE5C388

Q36868568-88F79DB1-6F58-41FE-A172-9A5D4A5AAD31

Q36868568-9F21ACED-A724-4BAE-9FCA-B558D105A3FA

Q36868568-A6B01C22-ED16-40E3-BF93-BD2B3564B2F5

Q36868568-AA2F76B0-7052-4F39-9988-F0163FBBBF04

Q36868568-B29620E7-5555-48F6-8870-998E4E7C356A

Q36868568-B2D1CFA3-983E-4B83-ACDE-9FCEDD9886D3

Q36868568-F51EE36B-DE95-4D01-BEDF-2FDA60A3DEC8

P2860

Q36868568-051AAF36-E0FE-4FE2-B552-8B6FF14074BF

Q36868568-25A056B9-AE2F-40A3-8F82-47284081A23F

Q36868568-2A92406B-7132-4F0D-AF81-DC38C9F0EBBF

Q36868568-2AA2D8CB-08FC-45BF-B28E-B8B5B873F701

Q36868568-33489CAB-3954-42B1-8754-8988A036906A

Q36868568-34DA030D-A0B9-403F-91E2-12346CFFD9B4

Q36868568-34E414F5-FD09-4AF2-AC43-490533C85016

Q36868568-37DAF370-3CD5-43F0-90F2-29624A64E9AF

Q36868568-38D6059E-8181-4023-84BE-73B1D6ADB82B

Q36868568-3B1F0E47-F3B6-4617-8C35-DE921F600A1F

P304

Q36868568-628A21C9-88D5-40E0-BBD4-267C727BB891

P31

Q36868568-D2D9816B-307E-4EB6-ACCE-E95FA385488D

P356

Q36868568-A4B1E6C1-9762-49D7-B31E-ADBA8F8F7D16

P407

Q36868568-A60B63CC-7490-4E0A-B546-B8ADF3109699

P433

Q36868568-C8347429-A097-4772-B640-165D74384FBA

P478

Q36868568-DAF3791E-796C-46DC-BE6B-07435EFA777F

P577

Q36868568-55762500-4C97-42DE-A5A7-F292CDB2242F

P5875

Q36868568-B7143379-8193-4F6E-8144-65587D39EA6A

P698

Q36868568-328A0CB3-461C-4154-A988-25FFA4CE6C90

P932

Q36868568-33D7DC68-D069-4CFB-B116-D78AA01627D9

P356

P1433

Journal of the American Medical Association

P1476

Low-dose physiological growth ...... a randomized controlled trial

@en

P2093

Bridget Canavan

http://www.w3.org/2001/XMLSchema#string

Greg Beltrani

http://www.w3.org/2001/XMLSchema#string

Hang Lee

http://www.w3.org/2001/XMLSchema#string

James Liebau

http://www.w3.org/2001/XMLSchema#string

Janet Lo

http://www.w3.org/2001/XMLSchema#string

Linda Hemphill

http://www.w3.org/2001/XMLSchema#string

Polyxeni Koutkia

http://www.w3.org/2001/XMLSchema#string

Steven Grinspoon

http://www.w3.org/2001/XMLSchema#string

Sung Min You

http://www.w3.org/2001/XMLSchema#string

P2860

Increased body fat mass and decreased extracellular fluid volume in adults with growth hormone deficiency

Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy.

Recombinant human growth hormone to treat HIV-associated adipose redistribution syndrome: 12 week induction and 24-week maintenance therapy.

The effects of low-dose growth hormone in HIV-infected men with fat accumulation: a pilot study

Effects of a supervised home-based aerobic and progressive resistance training regimen in women infected with human immunodeficiency virus: a randomized trial.

Effects of obesity, body composition, and adiponectin on carotid intima-media thickness in healthy women.

Growth hormone enhances thymic function in HIV-1-infected adults

Body size and shape changes and the risk of diabetes in the diabetes prevention program.

Premature mortality due to cardiovascular disease in hypopituitarism.

Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV).

P304

509-519

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.300.5.509

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

300

http://www.w3.org/2001/XMLSchema#string

P577

2008-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23146325

http://www.w3.org/2001/XMLSchema#string

P698

18677023

http://www.w3.org/2001/XMLSchema#string

P932

2532757

http://www.w3.org/2001/XMLSchema#string